8-KThe WireRoutine
Shareholder Vote
Filed Feb 24, 2026 · 4mo ago · Accession 0001193125-26-065234
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Xilio Therapeutics, Inc.
- Ticker
- XLO
- CIK
- 1840233
- Form type
- 8-K
- Filing date
- Feb 24, 2026
- Report date
- Feb 23, 2026
- Document
- xlo-20260223.htm
- Size
- 184 KB